tirzepatide
How a GLP-1 ‘Shadow System’ Puts Patients’ Safety at Risk
Dozens of unscrupulous web-based sellers of glucagon-like peptide-1 agonist drugs are evading FDA scrutiny and ...
NOVEMBER 16, 2024
Study Finds GLP-1s Safe and Effective For Managing Obesity in Patients With IBD
GLP-1s are well tolerated and effective for weight loss in patients with IBD, according to new research
OCTOBER 31, 2024
Expert Picks From EASL 2024
Ashwani K. Singal, MD, MS, highlights four abstracts from EASL Congress 2024.
OCTOBER 30, 2024
MASH Therapy Pipeline Growing, With a Mix of Results
After years without drug treatments for metabolic dysfunction–associated steatohepatitis, recently data have ...
AUGUST 22, 2024
GLP-1RA Use Increases Gastric Food Retention Post-Endoscopy—But Fasting Mitigates This
Although patients appear more likely to retain stomach contents during endoscopic procedures, this risk may ...
MAY 19, 2024
Advances Usher In Era of Personalized Treatment for Obesity
The multifaceted, complex medical problem that is obesity is seeing big advances that are starting to have a major ...
JANUARY 15, 2024
